Please login to the form below

Not currently logged in
Email:
Password:

Relvar

This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.

Elan buys into GSK-partnered Theravance programmes for $1bn

Elan buys into GSK-partnered Theravance programmes for $1bn

Aside from Breo ( known as Relvar outside the US), Elan will get royalties on sales of COPD combination therapy Anoro ( umeclidinium bromide and vilanterol), vilanterol as a monotherapy and GSK961081, a

Latest news

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
firstlight

Having a good story just isn’t good enough in today’s communications landscape. The audiences we need to reach are more...

Latest intelligence

Business in the USA
The pharma business environment in the US
Tighter regulations, more pricing controls and increased international competition will drive market improvements...
babylon virtual health service
VIDEO: Switching to a virtual health service
Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone...
Online Physician Communities
Is the pharma industry bad?
Surveys of doctors and the public suggest not...